These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 8354928)

  • 1. Liposome-encapsulated ciprofloxacin is effective in the protection and treatment of BALB/c mice against Francisella tularensis.
    Di Ninno VL; Cherwanogrodzky JW; Wong JP
    J Infect Dis; 1993 Sep; 168(3):793-4. PubMed ID: 8354928
    [No Abstract]   [Full Text] [Related]  

  • 2. Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection.
    Wong JP; Yang H; Blasetti KL; Schnell G; Conley J; Schofield LN
    J Control Release; 2003 Oct; 92(3):265-73. PubMed ID: 14568408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice.
    Conley J; Yang H; Wilson T; Blasetti K; Di Ninno V; Schnell G; Wong JP
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1288-92. PubMed ID: 9174185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of liposome-encapsulated ciprofloxacin as a tularemia therapy.
    Hamblin KA; Wong JP; Blanchard JD; Atkins HS
    Front Cell Infect Microbiol; 2014; 4():79. PubMed ID: 24995163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consequences of delayed ciprofloxacin and doxycycline treatment regimens against Francisella tularensis airway infection.
    Rotem S; Bar-Haim E; Cohen H; Elia U; Ber R; Shafferman A; Cohen O
    Antimicrob Agents Chemother; 2012 Oct; 56(10):5406-8. PubMed ID: 22850512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of murine pneumonic Francisella tularensis infection with gatifloxacin, moxifloxacin or ciprofloxacin.
    Steward J; Piercy T; Lever MS; Simpson AJ; Brooks TJ
    Int J Antimicrob Agents; 2006 May; 27(5):439-43. PubMed ID: 16621457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo efficacy of fluoroquinolones against systemic tularaemia infection in mice.
    Piercy T; Steward J; Lever MS; Brooks TJ
    J Antimicrob Chemother; 2005 Dec; 56(6):1069-73. PubMed ID: 16223941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of tularemia with ciprofloxacin.
    Scheel O; Reiersen R; Hoel T
    Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):447-8. PubMed ID: 1425715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoaerosols reduce required effective dose of liposomal levofloxacin against pulmonary murine Francisella tularensis subsp. novicida infection.
    Propst CN; Nwabueze AO; Kanev IL; Pepin RE; Gutting BW; Morozov VN; van Hoek ML
    J Nanobiotechnology; 2016 Apr; 14():29. PubMed ID: 27090889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of ciprofloxacin and doxycycline against experimental tularaemia.
    Russell P; Eley SM; Fulop MJ; Bell DL; Titball RW
    J Antimicrob Chemother; 1998 Apr; 41(4):461-5. PubMed ID: 9598777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of liposome-encapsulated ciprofloxacin on phagocytosis, nitric oxide and intracellular killing of Staphylcoccus aureus by murine macrophages.
    Wong JP; Schnell G; Simpson M; Saravolac E
    Artif Cells Blood Substit Immobil Biotechnol; 2000 Sep; 28(5):415-28. PubMed ID: 11009114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Needle-Free Delivery of Acetalated Dextran-Encapsulated AR-12 Protects Mice from Francisella tularensis Lethal Challenge.
    Hoang KV; Curry H; Collier MA; Borteh H; Bachelder EM; Schlesinger LS; Gunn JS; Ainslie KM
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2052-62. PubMed ID: 26787696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of tularemia with ciprofloxacin.
    Chocarro A; Gonzalez A; Garcia I
    Clin Infect Dis; 2000 Aug; 31(2):623. PubMed ID: 10987739
    [No Abstract]   [Full Text] [Related]  

  • 14. The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Francisella tularensis SCHU S4 Infection in BALB/c Mice and Cynomolgus Macaques.
    Grossman TH; Anderson MS; Christ D; Gooldy M; Henning LN; Heine HS; Kindt MV; Lin W; Siefkas-Patterson K; Radcliff AK; Tam VH; Sutcliffe JA
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The chemotherapeutic efficacy of ciprofloxacin and lomefloxacin in the inhalation method of infecting white mice with tularemia].
    D'iakov SI; Bubnov VP; Lebedeva IK; Sidorenko SV; Moskalenko VI
    Antibiot Khimioter; 2000; 45(6):17-20. PubMed ID: 10904804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Meningitis caused by Francisella Tularensis].
    Hakola K; Savola J
    Duodecim; 1996; 112(14):1300-2. PubMed ID: 10596102
    [No Abstract]   [Full Text] [Related]  

  • 17. Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis.
    Magallanes M; Dijkstra J; Fierer J
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2293-7. PubMed ID: 8285608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tularemia of the head and neck: a possible sign of bioterrorism.
    Stupak HD; Scheuller MC; Schindler DN; Ellison DE
    Ear Nose Throat J; 2003 Apr; 82(4):263-5. PubMed ID: 12735158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A spontaneous mutation in kdsD, a biosynthesis gene for 3 Deoxy-D-manno-Octulosonic Acid, occurred in a ciprofloxacin resistant strain of Francisella tularensis and caused a high level of attenuation in murine models of tularemia.
    Chance T; Chua J; Toothman RG; Ladner JT; Nuss JE; Raymond JL; Biot FV; Demons S; Miller L; Halasohoris S; Mou S; Koroleva G; Lovett S; Palacios G; Vietri NJ; Worsham PL; Cote CK; Kijek TM; Bozue JA
    PLoS One; 2017; 12(3):e0174106. PubMed ID: 28328947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.